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Genome-wide CRISPR screen 
reveals novel host factors required 
for Staphylococcus aureus 
α-hemolysin-mediated toxicity
Sebastian Virreira Winter, Arturo Zychlinsky & Bart W. Bardoel†
Staphylococcus aureus causes a wide variety of infections and antibiotic resistant strains are a major 
problem in hospitals. One of the best studied virulence factors of S. aureus is the pore-forming toxin 
alpha hemolysin (αHL) whose mechanism of action is incompletely understood. We performed a 
genome-wide loss-of-function screen using CRISPR/Cas9 technology to identify host targets required 
for αHL susceptibility in human myeloid cells. We found gRNAs for ten genes enriched after intoxication 
with αHL and focused on the top five hits. Besides a disintegrin and metalloproteinase domain-
containing protein 10 (ADAM10), the host receptor for αHL, we identified three proteins, Sys1 golgi 
trafficking protein (SYS1), ADP-ribosylation factor 1 (ARFRP1), and tetraspanin-14 (TSPAN14) which 
regulate the presentation of ADAM10 on the plasma membrane post-translationally. Interestingly, we 
also showed that cells lacking sphingomyelin synthase 1 (SGMS1) resist αHL intoxication, but have only 
a slightly reduced ADAM10 surface expression. SGMS1 regulates lipid raft formation, suggesting that 
αHL requires these membrane microdomains for attachment and cytotoxicity.
Staphylococcus aureus infections range from mild skin to life–threatening, disseminated diseases. The recent rise 
of multidrug-resistant strains complicates effective treatment of these infections and is a major public health 
concern. S. aureus effectively disarms the innate immune system by exploiting several immune evasion strate-
gies1. Alpha hemolysin (α HL) is an important S. aureus toxin and is essential for virulence in different infection 
models2–4.
α HL oligomerizes and forms pores on the host cell plasma membrane of a wide variety of cells. It can either 
trigger cell death or modulate several cellular processes, including cytokine production and proliferation2. α HL 
interacts with A Disintegrin And Metalloproteinase domain-containing protein 10 (ADAM10), which serves as 
its receptor5. ADAM10 is a transmembrane protease, shedding numerous targets such as TNF-α , HB-EGF or 
Notch, thereby modifying cellular signaling6. Most of ADAM10’s substrates are shared with other ADAM family 
members and ADAM10 expression in different cells correlates with susceptibility to α HL. Indeed, α HL binding 
increases ADAM10’s protease activity, which disrupts the epithelial barrier function and leads to lethal lung 
injury, as shown via ADAM10 conditional knockouts in the lung7.
Clustered regularly interspaced short palindromic repeats (CRISPR) and Cas genes form a prokaryotic 
immune system that is encoded in many bacteria and archaea8. The CRISPR/Cas9 system from Streptococcus 
is now used for targeted disruption and modification of genes in human cells9. Cas9 is a nuclease that can be 
directed to the sequence of interest by a guidance RNA (gRNA) sequence to create double strand breaks in the 
DNA. This induces activation of the host repair mechanisms, often resulting in improper repair of the lesion site 
and disruption of the target gene. Recently, synthesis of a CRISPR library containing 120,000 gRNAs targeting 
more than 19,000 human genes paved the way for genome-wide screening in human cells10.
In this study, we used this genome-wide screening approach to identify host factors required for α HL cyto-
toxicity. Lately, it has been reported that myeloid-specific effects of α HL are important determinants for the out-
come of infection11. Therefore, we chose the human myeloid cell line U937 for our experiments. We transduced 
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these cells with a CRISPR library targeting 19,050 human genes and 1864 miRNAs and intoxicated with α HL to 
obtain survivors that contain a mutation in genes essential for α HL-mediated cell death. Sequencing revealed the 
enrichment of genes that are involved in α HL toxicity including ADAM10. Single-cell cloning and complemen-
tation confirmed that all further analyzed hits from the screen are required for α HL-mediated cell death. Three 
genes regulate ADAM10 post-translationally and their deficiency reduces ADAM10 levels on the surface, thereby 
decreasing toxin binding. The importance of lipid rafts is underlined by the requirement of sphingomyelin syn-
thase 1 (SGMS1) to allow binding of α HL to the host cell.
Results
Genome-wide CRISPR screen reveals novel host factors required for αHL susceptibility. To 
identify host genes required for α HL toxicity, we used a genome-wide CRISPR library generated by the Zhang 
laboratory10,12. This library contains over 120,000 gRNAs with 6 gRNAs per gene for 19,050 human genes and 
4 gRNAs per miRNA. We first determined the toxicity of α HL on the human myeloid cell line U937 via flow 
cytometry by gating for DRAQ7-negative (a membrane-impermeable dye) cells with a forward and side scatter 
comparable to untreated cells (Supplementary Fig. S1). More than 85% of U937 cells were killed by 0.5 μg/ml 
of α HL overnight and we used this dose to perform the screen (Fig. 1a). We transduced U937 cells with the 
CRISPR library at an MOI of 0.3–0.5 and selected for cells with stable viral integration. Subsequently, we intox-
icated the cells with α HL or diphtheria toxin (DT), as control, for two weeks to allow outgrowth of resistant 
mutants. We isolated the genomic DNA of the survivors, amplified the gRNA sequences by PCR and analyzed 
by high-throughput sequencing which gRNAs are present in the toxin-resistant cells (Supplementary Fig. S2).
The targets of DT, which blocks translation and therefore has a different mechanism than α HL, were well 
characterized by genome-wide screening approaches13,14 and served as a control in our experiments. Cells trans-
duced with the CRISPR library and cultured without toxins for two weeks contained 88% of all gRNAs present 
in the library, whereas selection with α HL or DT decreased the amount of identified gRNAs below 30%. The 
number of reads per gRNA, expressed as fold of the median read number, ranged from 0.1–28 (unselected cells) 
to 0.2–15569 (α HL) and 0.2–57965 (DT), showing that intoxication with α HL or DT enriches a small portion of 
the gRNAs. For further analysis, we calculated the enrichment of each gRNA after intoxication compared to the 
untreated CRISPR library-transduced cells. The enrichment of multiple gRNAs per gene is the best indicator of a 
valid hit. As expected, we identified HBEGF, WDR85 and factors involved in diphthamide synthesis (DPH7 and 
DNAJC24) as genes required for susceptibility to DT (Fig. 1b)13. We found at least three gRNAs enriched twofold 
(log2 enrichment compared to unselected cells > 1) for 5 genes following DT intoxication. Selection with α HL 
resulted in ten genes with at least three gRNAs enriched (Supplementary Table 1). As the top hits, we identified 
the receptor ADAM10, which is known to bind the toxin, and four additional genes: Sys1 golgi trafficking protein 
(SYS1), ADP-ribosylation factor 1 (ARFRP1), tetraspanin-14 (TSPAN14) and sphingomyelin synthase 1 (SGMS1) 
Figure 1. Genome-wide CRISPR screen identifies novel αHL host targets. (a) U937 cells were incubated 
with various concentrations of α HL overnight and the percentage of viable cells was analyzed by flow 
cytometry. Data represent mean values of three independent experiments + SD. (b,c) Individual enrichment 
(log2) of gRNAs is shown for the most enriched genes following intoxication with DT (b) or α HL (c). Ranking 
is based on the median enrichment (log2) among all six gRNAs present in the library. (d) Median enrichment of 
six gRNAs for the 20 most enriched genes in the α HL screen is shown .
www.nature.com/scientificreports/
3Scientific RepoRts | 6:24242 | DOI: 10.1038/srep24242
(Fig. 1c,d). For these five genes, at least four out of six gRNAs were enriched more than nine fold and we therefore 
selected them for further analyses.
Cells targeted for screening hits are resistant to αHL. To validate these five genes, we selected two 
of the highly enriched gRNAs to target each hit in U937 cells. As a control, we used either a scrambled 20 nucle-
otide gRNA or a gRNA targeting neutrophil elastase, a gene unlikely to be involved in α HL-mediated toxicity, 
and referred to as “control gene” in this report. Cells transduced with gRNAs against any of the candidates, but 
not the controls, became resistant to α HL (Supplementary Fig. S3). This confirms that the screen identified genes 
involved in α HL toxicity and that the enrichment cut-off to select candidates for further analyses was stringent.
The CRISPR/Cas9 system introduces double-strand breaks (DSBs) efficiently, although a successful disrup-
tion of the target gene only occurs if a frameshift mutation is introduced by DNA repair mechanisms in both 
alleles. Transduction with an individual gRNA produces a heterogeneous population of cells where some cells 
have either no mutation or inframe mutations that still encode a functional protein. This “untargeted” population 
can explain the incomplete resistance and differences in survival between targeted genes in pooled populations 
(Supplementary Fig. S3). Furthermore, the difference in efficiency using different gRNAs has been observed in 
other CRISPR/Cas9 screens14. To avoid this heterogeneity, we obtained single cell clones by limiting dilution. 
As expected, we isolated both toxin-resistant and -susceptible clones (Fig. 2a–e). Notably, we observed that the 
frequency of frameshift mutations introduced varies between gRNAs with ADAM10 gR1 being the most efficient 
as we did not obtain any toxin-susceptible clones. In contrast, we identified both toxin-resistant and -susceptible 
clones using ADAM10 gR2 (Fig. 2a and Supplementary Fig. S4). Successful targeting of SYS1, ARFRP1, TSPAN14 
and SGMS1 occurred in around 50% of the clones, which correlates with the results obtained with mixed cell 
populations (Supplementary Fig. S3). In contrast to cells lacking ADAM10, around 20% of SYS1-, ARFRP1-, 
TSPAN14-, and SGMS1-targeted cells are susceptible to a high α HL concentration of 3 μg/ml.
To rule out that the toxin-resistant clones resulted from off-target mutations, we complemented the clones 
by overexpressing CRISPR-resistant genes. We introduced silent mutations in regions targeted by the gRNAs 
to avoid disruption of the overexpression constructs by CRISPR/Cas9. Lentiviral complementation of SYS1-, 
ARFRP1-, TSPAN14- and SGMS1-targeted cells restored susceptibility to α HL (Fig. 2f). However, none of the 
identified hits conferred resistance to streptolysin O (SLO), a pore-forming toxin of group A, C and G streptococci 
Figure 2. Individual targeting of the αHL hits results in αHL-resistant cells. (a–e) U937 clones derived 
from single cells by limiting dilution for each of the two gRNAs targeting (a) ADAM10, (b) SYS1, (c) ARFRP1, 
(d) TSPAN14 or (e) SGMS1 were incubated with 1 μg/ml of α HL overnight. Percentage of viable cells was 
determined by flow cytometry and gating for DRAQ7-negative and forward side scatter characteristics 
as control U937 cells. As a control, a random scrambled and a gRNA targeting an unrelated control gene 
(neutrophil elastase, NE) were included. (f) For each target gene, a CRISPR-targeted clone was complemented 
with a copy of the gene, modified via silent mutations to avoid editing by Cas9. Transduction with an empty 
vector served as a control. Cells were stimulated with 0.3 μg/ml α HL and after 40 hours the percentage of viable 
cells was measured by flow cytometry. All graphs (a–f) represent mean + SD of three independent experiments. 
(f) Statistical testing was performed using t test and p values are indicated.
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(Supplementary Fig. S5). These results confirm that the genes we identified in the genome-wide CRISPR screen 
are required for α HL toxicity.
Screening hits are essential for αHL binding to cells. TSPAN14 was previously associated with 
ADAM10 surface expression15,16. SYS1 and ARFRP1 interact with each other and play a role in protein trafficking 
in the Golgi apparatus17, although there is no known link with either ADAM10 or α HL susceptibility. SGMS1 
synthesizes sphingomyelin, a major constituent of the plasma membrane, and is involved in the formation of lipid 
rafts18. Cells lacking SGMS1 show reduced sphingomyelin levels on their plasma membrane and are resistant to 
cytolethal distending toxins (CDTs), suggesting that, like for CDTs, lipid rafts are required for α HL-mediated 
toxicity13.
To address if these genes are required for α HL binding, we incubated cells with fluorescently labeled α HL. 
We introduced a cysteine at the C-terminus of α HL, which does not contain any endogenous cysteine residues, 
to allow site-specific labeling with the fluorescent dye Alexa Fluor 647 (Supplementary Fig. S6). The fluorescent 
α HL bound to control cells but not to cells with a gRNA targeting ADAM10 (Fig. 3a), which correlates with 
previous findings5. Disruption of SYS1, ARFRP1, TSPAN14 or SGMS1 decreased α HL binding to U937 cells. 
Analysis by live cell microscopy revealed that α HL binds to the host cell within minutes (Supplementary Video 1). 
Furthermore, confocal imaging confirmed that targeting any of the candidate genes prevents binding of α HL to 
the cell surface (Fig. 3b). These experiments demonstrate that the selected hits of our screen impair α HL activity 
by preventing binding of the toxin to the cells.
SYS1, ARFRP1 and TSPAN14 regulate ADAM10 surface expression. Decreased binding of α HL to 
the cells suggests that all hits identified in the screen interact directly with the toxin or influence factors involved 
in toxin-cell interaction. The only proposed α HL-interacting protein is ADAM10 and cells lacking this receptor 
are resistant to α HL5. To analyze if there was a decrease in ADAM10 expression in cells lacking SYS1, ARFRP1, 
TSPAN14, or SGSM1, we quantified ADAM10 transcription by qRT-PCR (Fig. 4a). None of these proteins regu-
late the transcription of ADAM10.
Since α HL interacts with ADAM10 on the cell surface5, we asked whether any of the candidate genes affects 
ADAM10 surface localization. We stained CRISPR-targeted cells with an antibody directed against the ectodo-
main of ADAM10. As expected, ADAM10 was not detected at the surface of ADAM10-targeted clones; the mean 
fluorescence intensity values were similar to an isotype control antibody (Fig. 4b and Supplementary Fig. S7). 
Notably, we also observed decreased surface levels of ADAM10 when the other genes were targeted: 60% reduc-
tion in SYS1 and ARFRP1 mutants, 80% in TSPAN14 mutants and 50% in SGMS1 mutants. In addition, confocal 
microscopy confirmed that targeting SYS1, ARFRP1, TSPAN14, and SGMS1 decreased ADAM10 surface staining 
and binding of α HL to cells (Fig. 4c and Supplementary Fig. S8). In control cells, α HL and ADAM10 colocalize at 
the plasma membrane after 5 minutes, whereas prolonged incubation results in their intracellular colocalization. 
These results suggest that deficiency in ARFRP1, SYS1, and TSPAN14 causes resistance to α HL at least partially 
because of reduced surface ADAM10 expression. Indeed, the partial susceptibility to high concentration of α HL 
when these three genes are mutated (Fig. 2a–e) might be explained by the residual expression of ADAM10 on 
the surface. This is consistent with the observation that SYS1-, ARFRP1- and TSPAN14-targeted cells bind and 
internalize low levels of α HL (Fig. 4c and Supplementary Fig. S8).
To test if targeting of the Golgi-resident proteins, SYS1 and ARFRP1, causes a common defect in protein traf-
ficking to the surface we determined the levels of ADAM15, a closely related ADAM family member, on the cell 
surface of U937 cells (Supplementary Fig. S9). Targeting any of the five genes did not affect the surface expression 
Figure 3. αHL binding is impaired in toxin-resistant CRISPR-targeted cells. (a) U937 cells were incubated 
with 0–1 μg/ml fluorescently labeled α HL for 30 minutes at 37 °C. For each gene we tested one α HL-resistant 
clone. Binding was analyzed by gating for DRAQ7-negative cells using flow cytometry and expressed relative 
to 0 μg/ml α HL. Graphs indicate mean + SD of three independent experiments and statistical testing was 
performed using unpaired one-way ANOVA with correction for multiple comparisons (Dunnett). (b) U937 
clones were challenged with 2 μg/ml α HL-Cys-His-Alexa647 for 5 minutes, fixed and stained with DAPI. 
Images were obtained by confocal microscopy. Nuclei (blue) and cell-bound α HL-Cys-His-Alexa647 (magenta) 
are shown. These are representative confocal z-planes of two independent experiments.
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of ADAM15, indicating that neither SYS1 nor ARFRP1 are general regulators of the localization of the ADAM 
protease family (Fig. 4d).
Targeting of SGMS1 reduces α HL toxicity strongly, although ADAM10 surface expression remains rel-
atively high compared to the other targeted genes (Fig. 4b and Supplementary Fig. S7). In SYS1-, ARFRP1- 
or TSPAN14-targeted cells, treatment with α HL reduces subsequent ADAM10 surface staining with an 
anti-ADAM10 antibody. This is in line with our findings that these cells bind low levels of α HL and internal-
ize it together with ADAM10. In contrast, labeling with an anti-ADAM10 antibody in SGMS1-targeted cells is 
unaffected even after incubation with 3 μg/ml of α HL (Fig. 4e). To check if ADAM10 processing in the Golgi is 
affected in any of the CRISPR-targeted clones, we performed western blot analysis of ADAM10 (Supplementary 
Fig. S10). ADAM10 was not detectable in ADAM10-targeted cells and targeting of SYS1, ARFRP1 and TSPAN14 
led to intracellular accumulation of the unprocessed, immature form of ADAM10, while targeting of SGMS1 did 
not affect ADAM10 maturation. These findings indicate that SGMS1-targeted cells display reduced α HL binding 
and toxicity independent of ADAM10 surface expression levels.
Discussion
The clinically relevant pathogen S. aureus secretes the pore forming toxin α HL as one of its most important 
virulence factors. We screened for genes required for the toxic activity of α HL in myeloid cells, which have 
recently been shown to be relevant target cells of α HL11, by employing the CRISPR/Cas9 technology. To control 
for the specificity of our screen, we treated cells with either DT or α HL. DT inhibits protein synthesis while 
α HL is a pore-forming toxin. As expected, the α HL screen identified different genes when compared to the 
diphtheria toxin screen, which was validated by identifying genes already known to be essential for diphtheria 
Figure 4. Surface ADAM10 regulates susceptibility to αHL. (a) CRISPR-targeted U937 cells were analyzed 
for gene expression of ADAM10, quantified by qPCR and expressed as relative value compared to the RPL32 
gene. (b) U937 clones targeted with the gRNAs to the indicated genes were incubated with an ADAM10 
antibody, followed by a PE-labeled secondary goat-anti-mouse antibody. Geometric mean of ADAM10-PE 
staining was analyzed by flow cytometry. Values represent the relative ADAM10 surface expression compared 
to control cells (WT U937 or cells transduced with scrambled gRNA). (c) U937 clones were intoxicated with 
2 μg/ml α HL-Cys-His-Alexa647 (magenta) for the indicated times, fixed, permeabilized and ADAM10 was 
visualized by staining with an anti-ADAM10 antibody (green). Nuclei were stained with DAPI (blue). Shown 
are representative confocal z-planes of two independent experiments. (d) U937 CRISPR clones were stained 
with anti-ADAM15 and analyzed by flow cytometry. Data are expressed as fold expression relative to scrambled 
control. (e) U937 CRISPR clones were incubated with either 0 or 3 μg/ml α HL overnight at 37 °C. Subsequently, 
surface expression of ADAM10 was analyzed by flow cytometry. Dots represent individual experiments of 
α HL resistant CRISPR clones. Data are plotted as relative ADAM10 surface expression compared to WT U937 
or scrambled at 0 versus 3 μg/ml α HL. (a,b,d) Shown are mean + SD of three independent experiments and 
statistical testing was performed using unpaired one-way ANOVA with correction for multiple comparisons 
(Dunnett). (c) representative images of two independent experiments.
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toxicity13,14. More importantly, in the α HL screen we confirmed that ADAM10 is the major target of the toxin 
as proposed by biochemical interaction and functional studies5. The screen identified ten genes for which at 
least three gRNAs were enriched and which have not previously been linked to α HL toxicity. During further 
analyses we found SYS1, ARFRP1 and TSPAN14 to be important for ADAM10 expression on the cell surface. We 
also identified SGMS1, which is required for α HL toxicity, but affects ADAM10 expression only moderately. All 
these genes are not required for the toxicity of the pore-forming toxin SLO, indicating that pore-forming toxins 
target host cells in diverse ways. Surprisingly, SGMS1-deficient cells were even more susceptible to SLO. This 
highlights the importance of plasma membrane lipids as determinants for toxin interactions with host cells. To 
further explore if there are more than the five hits among the ten identified candidates, we targeted SMIM15 and 
PRDM15 with three gRNAs each and found that they exhibit increased resistance to α HL compared to control 
cells (Supplementary Fig. S11). Interestingly, genes associated with the Nlrp3 inflammasome were not identified 
in our screen, even though it has been reported that α HL can active Nlrp3 in monocytic cells19,20. This might be 
explained by differences in the cells used since murine bone marrow-derived macrophages also do not activate 
Nlrp3 in response to recombinant α HL and it is not clear whether α HL activates Nlrp3 directly or via substances 
released from intoxicated cells. Also other genes that have been linked previously to α HL susceptibility, includ-
ing apoptotic caspases, were not identified in this screen21–24. Possible reasons are pathway redundancy and the 
stringent selection for survivors with α HL for two weeks, biasing against non-essential modulators of α HL intox-
ication. In conclusion, additional host targets of α HL may exist, since genetic screens fail to identify redundant or 
essential genes and our study is limited to U937 cells.
Several members of the tetraspanin (TSPAN) family, including TSPAN14, play an important role in matura-
tion and trafficking of ADAM1015. Our data indicate that TSPAN14 is the dominant TSPAN regulating ADAM10 
surface expression in U937 cells. Even though gRNAs targeting other TSPANs were included in the GeCKO 
library, no other TSPAN had at least two gRNAs enriched after α HL treatment, suggesting that other TSPANs 
have no function in regulating ADAM10 or are not expressed in U937 cells. SYS1 and ARFRP1 interact and form 
a protein complex17. SYS1 targets ARFRP1 to the Golgi apparatus, where it interacts with proteins that coordinate 
the Golgi function. The relevance of these proteins in neither ADAM10 surface expression nor α HL toxicity was 
known. ADAM10 has a Golgi retention signal and is mostly found in its inactive form within this organelle25. 
Our data demonstrate that SYS1 and ARFRP1 regulate trafficking of ADAM10 to the surface in its active form. 
Interestingly, our results suggest that SYS1 and ARFRP1 are not general regulators of protein trafficking since 
levels of ADAM15, which is closely related to ADAM10, were unaffected in cells where SYS1 or ARFRP1 were 
not functional. Together these data highlight that ADAM10 delivery to the plasma membrane has a dedicated 
control pathway.
SGMS1 is required for toxic activity of CDTs, which are AB toxins with DNase activity13. Although the mech-
anism of action of CDTs differs from α HL, both toxins require binding to a receptor expressed on the plasma 
membrane. SGMS1 regulates the sphingomyelin content in the outer leaflet of the plasma membrane, which is 
involved in lipid raft formation18. Several studies showed that clustered sphingomyelin-cholesterol domains are 
required for pore formation by α HL26,27. Furthermore, α HL induces ADAM10 cluster formation and subsequent 
relocalization to lipid rafts5,28. Affecting lipid rafts by targeting SGMS1 may explain the α HL-resistant phenotype 
of cells without extensive downregulation of ADAM10 surface expression.
The exact mechanism by which ADAM10 is involved in α HL toxicity is still unclear. Outcomes of α HL intox-
ication depend on the dose and the cell type. Low concentrations of toxin induce apoptosis, whereas higher 
concentrations cause unspecific, ADAM10-independent, binding and killing5,29. We used a low concentration of 
α HL, sufficient to kill most cells after overnight incubation whilst avoiding unspecific binding and killing of the 
cells. In addition to the requirement of ADAM10 for α HL binding, it has also been shown that α HL increases 
the proteolytic activity of ADAM10 triggering tissue damage30. Our observations that both ADAM10- and 
SGMS1-targeted cells allow no α HL binding or α HL-induced ADAM10 uptake favor the model of a cooperative 
interaction of α HL with a proteinaceous receptor, ADAM10, in combination with lipids such as sphingomyelin2.
Recently, Popov et al. published an elegant screen for α HL using mutagenized human haploid cells31. These 
investigators also identified ADAM10 as a required gene and showed that PLEKHA7 and other junctional com-
ponents were also necessary for α HL toxicity. Interestingly, they picked up TSPAN33, suggesting that different 
members of the TSPAN family are required in different cells for ADAM10 presentation on the cell surface. The 
difference between the two screens may be due to both the methodology and the origin of cell. It will certainly be 
interesting to test whether the genes found in both screens have a function in other cells, although myeloid cells 
do not have junctions. It would be interesting to show the function of these genes in vivo, however the contribu-
tion of the identified genes in our screen is difficult to address in vivo since knockouts for all the identified genes 
are embryonic lethal in mice. More importantly, the results obtained by Popov et al. and our data likely point to 
the difference in α HL toxicity functions between diverse target cells and might explain the diverse pathogenesis 
of S. aureus.
The identification of genes required for proper ADAM10 trafficking is of great interest since this protease is 
also relevant in Alzheimer’s disease (AD)32,33. Aggregation of the amyloidβ peptide causes amyloid plaque forma-
tion in the brain which is a hallmark of AD34. ADAM10 processes the amyloidβ precursor preventing its aggrega-
tion and amyloid plaque formation25. Boosting ADAM10 activity has potential therapeutic relevance33. Since the 
identified hits in this study target yet unidentified players in ADAM10 regulation they may provide novel avenues 
to understand the role of ADAM10 in AD.
α HL plays a crucial role in S. aureus infections as illustrated by different infection models3,4. We, like Popov 
et al., find in an unbiased screen that ADAM10 is the main target of α HL. Additional genes identified in our 
screen underline this, showing an important role in the regulation of ADAM10 expression. The requirement of 
SGMS1 illustrates the importance of membrane composition for α HL-mediated cytotoxicity. These findings help 
to further improve our understanding of the molecular pathogenesis of S. aureus infections.
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Materials and Methods
Cells and reagents. U937 and HEK293T cells were obtained from ATCC and DSMZ, respectively. Cells 
were propagated in RPMI or DMEM, supplemented with 10% FCS, glutamine and penicillin/streptomycin. 
ViraPower packaging mix (Thermo Fisher Scientific) was used to produce pseudotyped lentivirus. α HL and 
diphtheria toxin were obtained from Sigma-Aldrich, SLO was purchased from AbD Serotec. Mouse IgG2b against 
the ectodomain of human ADAM10, mouse IgG1 against human ADAM15 and isotype controls were from R&D 
Systems. Mouse IgG1 against human ADAM10 (clone 11G2) was from abcam and rabbit IgG against human 
GAPDH (clone 14C10) was from Cell Signaling Technology. DRAQ7 was purchased from BioStatus. Alexa Fluor 
647 C2 Maleimide and DAPI were from Thermo Fisher Scientific and PE-labeled goat anti-mouse IgG was from 
BioLegend. Human GeCKO v2 Library (Addgene #1000000048) and lentiCRISPR v2 (Addgene plasmid # 52961) 
were obtained from Addgene.
CRISPR screen. The human GeCKO v2 library containing 120,000 gRNA sequences in the lentiCRISPR v2 
vector containing Cas9 was transformed into E. coli as described12. Briefly, 293T cells were transfected with 
isolated plasmid pool of the GeCKO v2 library and ViraPower packaging plasmids for lentivirus production. 
Lentivirus was harvested and concentrated by centrifugation before U937 cells were transduced. 
After two days, 2.5 μg/ml puromycin was added to select for transduced cells. Surviving cells were incubated 
with 0.5 μg/ml α HL or 10 ng/ml diphtheria toxin 7 days after transduction for two weeks. The unselected 
library was also kept in culture before isolating the DNA. A 1st PCR was performed with primers 
5′-AATGGACTATCATATGCTTACCGTAACTTGAAAGTATTTCG-3′ and 5′-TCTACTATTCTTTCCCC 
TGCACTGTTGTGGGCGATGTGCGCTCTG-3′ annealing up- and downstream of the gRNA sequence. The PCR 
product was purified and a 2nd PCR was performed with primers 5′-TCTTGTGGAAAGGACGAAACACCG-3′ 
and 5′-TCTACTATTCTTTCCCCTGCACTGT-3′ annealing at the sequence that was introduced using the prim-
ers of the 1st reaction. The PCR product containing gRNA sequences that were integrated into the genomes of 
the cells were sequenced by parallel sequencing using a HiSeq 2000 (Illumina). Reads for each gRNA were nor-
malized to counts per million total reads and all counts below 5 were set to 5 per million reads to remove noise 
of low read counts and avoid that gRNAs appear enriched when all reads are below 5 and hence within noise. 
Enrichment of each individual gRNA was calculated compared to the unselected U937 cells and expressed as log2 
enrichment. Enrichment data were plotted as a heatmap using the GENE-E tool (http://www.broadinstitute.org/
cancer/software/GENE-E/index.html).
Complementation. Sequences of the genes SYS1, ARFRP1, TSPAN14, and SGMS1 were modified in the 20 
nucleotide CRISPR region and PAM sequence for all six gRNAs present in the CRISPR library with at least four 
mutations without changing the amino acid sequence. The modified sequences were synthesized and cloned into 
pLenti6/V5-DEST (Thermo Fisher Scientific). The pLenti6/V5-DEST with genes of interest or the empty vector 
were used to generate lentivirus to transduce U937 cells. After transduction, cells were selected with 10 μg/ml 
blasticidin.
Flow cytometry. Cells were challenged with the indicated concentrations (0–3 μg/ml) of α HL for 
20–40 hours. The cells were centrifuged and resuspended in 100 μl RPMI + 0.5% HSA containing 0.5 μg/ml 
anti-ADAM10/anti-ADAM15 antibody or the corresponding isotype control. After incubation for 30 minutes 
at 4 °C, cells were washed and incubated with PE labeled goat anti-mouse IgG as secondary antibody and 0.6 μM 
DRAQ7 for 30 minutes at 4 °C. To determine susceptibility to SLO, cells were challenged with 0–10 μg/ml of SLO 
for six hours, washed with PBS and resuspended in 0.6 μM DRAQ7 in 0.5% FCS/PBS. After washing cells, the 
staining was analyzed using a MACSQuant Analyzer 10 flow cytometer and data were analyzed by FlowJo v10. 
The percentage of viable cells was determined by gating DRAQ7-negative cells with an unaffected forward and 
side scatter compared to untreated cells.
To analyze α HL binding, cells were resuspended in 100 μl RPMI with 0.5% HSA and then intoxicated with 
varying concentrations of α HL-Cys-His-Alexa647 for 30 minutes at 37 °C. Cells were put on ice, washed and cells 
with a disrupted membrane integrity were marked with 2.5 μg/ml DAPI and excluded from the analysis. Binding 
of α HL was determined by quantifying Alexa Fluor 647 fluorescence by flow cytometry.
qPCR. Total RNA was isolated from CRISPR-targeted cells with TRIzol, according to the manufactur-
er’s protocol. cDNA was synthesized from purified RNA using QuantiTect Reverse Transcription kit from 
Qiagen. qPCR was performed using SYBR Green PCR Master Mix (Thermo Fisher Scientific) and ADAM10 
primers (GTGTACGTGTGCCAGTTCTGATG & CTGAAGTGCCTACTCCACTGC) or RPL32 primers 
(CATCTCCTTCTCGGCATCA & AACCCTGTTGTCAATGCCTC) as a control.
Microscopy. Cells were intoxicated with α HL-Cys-His-Alexa647 in RPMI, supplemented with 10% FCS, 
2 mM glutamine and penicillin/streptomycin. After the indicated times, cells were fixed with a final concentra-
tion of 2% paraformaldehyde. Cells were washed after 10 minutes with PBS, permeabilized with 0.1% saponin for 
10 minutes and blocked with 1% BSA/PBS for 15 minutes. To stain ADAM10, cells were incubated with 2 μg/ml 
anti-ADAM10 (11G2) for 2 hours at room temperature. After washing in PBS, cells were incubated with 4 μg/ml 
anti-mouse IgG-Alexa488 antibody for 1 hour at room temperature. Finally, cells were washed several times in 
PBS, incubated for 5 minutes with 2.5 μg/ml DAPI, washed again and imaged. Colocalization analysis was per-
formed on entire Z-stacks using ImageJ and the Coloc 2 plugin with the Costes significance test (100 iterations).
For live cell imaging, cells were resuspended in Live Cell Imaging Solution (Thermo Fisher Scientific), supple-
mented with 10% FCS, 2 mM glutamine, 1x MEM vitamin solution, 4 g/L glucose and penicillin/streptomycin. 
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Imaging was performed at 37 °C using a Leica TCS SP8 confocal microscope. Cells were then intoxicated with 
2 μg/ml α HL-Cys-His-Alexa647 10 minutes after acquisition was started.
Expression and labeling of αHL. The α HL gene was synthesized and modified by adding a C-terminal 
cysteine followed by a thrombin cleavage site and a His-Tag. The modified gene was cloned into pET28a, trans-
formed into E.coli BL21 and induced with 0.5 mM IPTG. His-tagged α HL was purified using HisTrap columns 
(GE Healthcare) according to the manufacturer’s protocol. Purified α HL was concentrated to 10 mg/ml and incu-
bated with 10x molar excess of Alexa Fluor 647 Maleimide for 2 h at room temperature. Excess dye was removed 
via HiTrap desalting columns (GE Healthcare).
Western blot. U937 cells were counted, washed twice with PBS and lysed in non-reducing Laemmli buffer. 
Two million cells were loaded per lane on a non-reducing SDS-PAGE gel. Gel was blotted on nitrocellulose mem-
brane and ADAM10 was detected with the monoclonal mouse anti-ADAM10 (11G2) antibody. As a loading 
control, GAPDH was detected via rabbit anti-GAPDH (14C10) antibody. Densitometric analysis to estimate the 
relative amount of processed ADAM10 was performed with ImageJ.
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